Topic Listing for Alpharma

Activities Compensation Committee 2006 Acute Pain
Additional Covenants Addressing Unmet Needs
Addressing Unmet Patient Needs Adjusted Relative Risk
Adjustments Administration
Administration Eligibility Adults Take Analgesics Each
Ahd Alo-04
Alpharma Defined Benefit Plan Alpharma Inc 2005 Supplemental Savings Plan
Alpharma Inc 2007 Supplemental Savings Plan Alpharma Inc Pension Plan
Alpharma Inc Supplemental Pension Plan Alpharma Inc Supplemental Savings Plan
Alpharma Pharmaceuticals Llc Alpharma Presence Over Total Pain Market
Amendment Modification Suspension Termination Amendment Plan
Amendments Loan Agreement Annual Incentive Awards
Api Appointment Jeffrey Campbell Chief Financial Officer Role
Arthur Weaver Facp Macr Assessments
Assumptions Regarding Post Termination Tables Audit Committee
Audit Committee Report Audit Non-audit Services Pre-approval Policy
Aue0-2h Awards
Balance Risk Beneficial Ownership Reporting Compliance
Beneficiary Designation Bid Dosing Acceptable Physicians
Board Committee Independence Board Meetings Annual Meeting Attendance Directors
Bpi Average Pain Score Daily Diary Bridgewater
Bridgewater Nj8230february 20088230 Capitalization Adjustments
Cash-based Awards Cash-based Awards Stock-based
Celecoxib Certain Other Relationships Transactions
Certain Relationships Related Transactions Change Control
Change Control General Severance Coverage Committee Operating Processes
Committees Board Communications Stockholders Other Interested Parties
Companies Recruited Include Abbott Astra-zeneca Bms Cephalon Eisai Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Processes Procedures
Compensation Committee Report Compensation Consultant
Compensation Determinations Adjustments Compensation Elements
Competitive Market Compensation Positioning Competitive Market Defined
Competitive Positioning Compensation Conditions Precedent
Consent Api Disposition Contents
Contributions Corporate Governance Principles Business Conduct Guidelines Code Ethics
Critical Success Factors Build Pain Franchise Deferrals Share Settlements
Delegation Authority Director Identification Selection
Division Presidents Only Carl-aake Carlsson Active Pharmaceutical Ingredients Dollar Deduction Limitation
Election Directors Electronic Telephonic Voting
Elements Compensation Eligibility Participation
Embeda Employment Agreements
Equity Compensation Plans Establishment Purpose Duration
Executive Attributes Executive Compensation
Executive Retirement Executive Sessions Outside Non-management Directors
Executive Termination Payments Executive Vice President Human Resources Communications
Expense Reimbursement Extremely Important
Federal Income Tax Consequences Flector Patch Characteristics
Flector Patch Clinical Data Flector Patch Market Research Summary Key Findings
Flector Patch133conclusion Form Release
Former Vice Chairman Board President Chief Executive Officer Forward Looking Statement
General Compensation Objectives General Compensation Philosophy
General Provisions Going 2008 2012
Grow Kadian Business Guidance
Health Life Insurance Disability Similar Benefits Held 2007
Held 2008 Http Wwwalpharmacom
Ibuprofen Impact Regulatory Similar Requirements
Increased Leadership Talent Infrastructure Growing Pharmaceuticals Business
Ingrid Wiik Contractual Pension Isos
Legal Construction Long Term Incentive Awards
Lower Systemic Blood Level Managed Care Strategy
Market Flector Patch Large Market Opportunities
Mds Believe Lao Patients Abuse Risk Median Time Pain Resolution
Modification Most Participants Had Neutral Favorable Reaction Flector Patch
N32 Max Score Naltrexone Levels Measured
Nominating Corporate Governance Committee Nominees Directors
Non-assignability Non-qualified Deferred Compensation
Nonqualified Deferred Compensation Nonspecific Nsaids Upper Lower Complications Previously Unrecognized Cardiac
Nqsos Nsaid Cox-2 Market Large Shifting
Objective Omnibus Incentive Compensation Plan
Option Exercises Stock Vested Organization
Other Awards Other Business
Other Consent Release Other Executive Compensation Programs
Over Abusers Say Friends Relatives Primary Source Illicit Overall Strategy Remains Unchanged133
Payment Death Disability Executives Payment Retirement Executives
Payments Certain Events Connection Sale Business Unit Change Payments Change Control Alpharma Carlsson Warner Wrenn
Payments Change Control Mitchell Campbell Payments Involuntary Termination Without Cause Absent Change Control
Payments Involuntary Termination Without Cause Sale Business Unit Payments Involuntary Termination Without Cause Voluntary Good Reason
Payments Sale Business Unit Carlsson Warner Wrenn Payments Termination Executives
Pension Benefits Performance Measures
Performance Shares Units Performance Stock Units
Perquisites Pharmaceuticals Invest Create High Value Specialty Pharma Business
Physicians Initial Response Flector Patch Been Extremely Favorable Placebo
Plan Administration Plan Award Terms
Plan Benefits Positioned Growth Value Creation
Presentation Available Listen Only Mode Via Internet Http Primary Endpoint
Principal Accountant Fees Services Principal Compensation Programs
Proposal Approve Amendment Restatement Alpharma Inc 2003 Omnibus Proposal Approve Amendment Restatement Alpharma Inc Employee Stock
Proposal Ratify Appointment Bdo Seidman Llp Accountants Proposal Ratify Appointment Bdo Seidman Llp Independent Registered
Proposed Amendment Proxies
Proxy Statement Annual Meeting Stockholders Held 2007 Proxy Statement Annual Meeting Stockholders Held 2008
Proxy Statement Annual Report Available Wwwedocumentviewcom Alo Purchasing Shares
Purpose Analysis Following Assumptions Respect Payments Sale Business Purpose Analysis Following Assumptions Respect Payments Termination Absent
Purpose Analysis Following Assumptions Respect Payments Termination Change Purpose Meeting
Quorum Rating Initial Impression
Record Date Shares Entitled Vote Regional Advisory Boards
Required Vote Responsibilities Processes
Restricted Stock Restricted Stock Units
Retention Agreements Retention Incentives
Retirement Savings Deferred Compensation Programs Reusage
Rights Employees Directors Role Executives
Sales Force Expansion Complete Sars
Scope Authority Shares Available Issuance
Shares Subject Espp Shares Subject Plan Maximum Awards
Significant Pipeline Growth Statement Policy
Stock Appreciation Rights Stock Options
Stock-based Awards Stockholders Proposals 2008 Annual Meeting
Stockholders Proposals 2009 Annual Meeting Strategic Opportunities Pharmaceuticals
Strategies Minimize Oral Nsaid-gastropathy Study 205 Pharmacodynamic
Study 301 Safety Population Study Design
Successors Summary
Synovial Fluid Taper Period
Termination Amendment Termination Plan
Total Nsaid Increasing Traditional Oral Nsaid Limitations Toxicity
Volume Voting Other Rights
What Well Talk About133 Withdrawal Rights Termination Employment
Withholding Womac Composite Score
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki